Skip to main content
Premium Trial:

Request an Annual Quote

Vitamin D From Tomatoes

Researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D, Reuters reports.

Vitamin D, it notes, is needed for the development of strong teeth and bones. While it is produced by the body following exposure to sunlight, Reuters adds that its major source is from dairy and meat. But according to the researchers from the John Innes Centre, about 1 billion people have low vitamin D levels, which can affect risk of diseases like cancer.

As they report in Nature Plants this week, they used CRISPR-Cas9 to coax 7-dehydrocholesterol, a vitamin D precursor that is also known as provitamin D3, to be produced by tomato fruit. It is already produced by tomato leaves. The Innes team reports that one of their tomatoes harbored 30 percent of the recommended daily vitamin D amount when green and 20 percent when red.

"I think that having a dietary source (of vitamin D) in the form of a plant also means that you can get added benefit from eating tomatoes. We don't eat enough fruit and veg anyway. A tomato is a good source of vitamin C as well," coauthor Cathie Martin from Innes said at a news briefing, according to CNN.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.